| Cancer-type | Pathway | Q-value | P-value | Pathway size | Cancer set size | DP | DN | GP | GN |
| jones_pancreas | hsa04512:ECM-receptor interaction | 8.43e-08 | 6.02e-10 | 73 | 170 | 14 | 156 | 73 | 8867 |
| jones_pancreas | hsa01430:Cell Communication | 1.61e-07 | 2.3e-09 | 82 | 170 | 14 | 156 | 82 | 8858 |
| jones_pancreas | hsa04510:Focal adhesion | 1.11e-06 | 2.39e-08 | 179 | 170 | 18 | 152 | 179 | 8761 |
| jones_pancreas | hsa05222:Small cell lung cancer | 5.83e-06 | 1.73e-07 | 83 | 170 | 12 | 158 | 83 | 8857 |
| jones_pancreas | hsa04730:Long-term depression | 5.83e-06 | 2.08e-07 | 68 | 170 | 11 | 159 | 68 | 8872 |
| jones_pancreas | hsa04520:Adherens junction | 5.5e-05 | 2.35e-06 | 71 | 170 | 10 | 160 | 71 | 8869 |
| jones_pancreas | hsa04350:TGF-beta signaling pathway | 0.000137 | 6.86e-06 | 81 | 170 | 10 | 160 | 81 | 8859 |
| jones_pancreas | hsa04530:Tight junction | 0.000148 | 8.44e-06 | 103 | 170 | 11 | 159 | 103 | 8837 |
| jones_pancreas | hsa05213:Endometrial cancer | 0.000191 | 1.23e-05 | 51 | 170 | 8 | 162 | 51 | 8889 |
| jones_pancreas | hsa04070:Phosphatidylinositol signaling system | 0.000222 | 1.58e-05 | 53 | 170 | 8 | 162 | 53 | 8887 |
| jones_pancreas | hsa04514:Cell adhesion molecules (CAMs) | 0.000287 | 2.46e-05 | 95 | 170 | 10 | 160 | 95 | 8845 |
| jones_pancreas | hsa05212:Pancreatic cancer | 0.000287 | 2.46e-05 | 75 | 170 | 9 | 161 | 75 | 8865 |
| jones_pancreas | hsa05220:Chronic myeloid leukemia | 0.000292 | 2.71e-05 | 76 | 170 | 9 | 161 | 76 | 8864 |
| jones_pancreas | hsa04310:Wnt signaling pathway | 0.000335 | 3.4e-05 | 121 | 170 | 11 | 159 | 121 | 8819 |
| jones_pancreas | hsa04010:MAPK signaling pathway | 0.000335 | 3.67e-05 | 223 | 170 | 15 | 155 | 223 | 8717 |
| jones_pancreas | hsa04080:Neuroactive ligand-receptor interaction | 0.000335 | 3.83e-05 | 197 | 170 | 14 | 156 | 197 | 8743 |
| jones_pancreas | hsa05223:Non-small cell lung cancer | 0.00107 | 0.00013 | 54 | 170 | 7 | 163 | 54 | 8886 |
| jones_pancreas | hsa04540:Gap junction | 0.00149 | 0.000192 | 78 | 170 | 8 | 162 | 78 | 8862 |
| jones_pancreas | hsa04630:Jak-STAT signaling pathway | 0.00153 | 0.000208 | 125 | 170 | 10 | 160 | 125 | 8815 |
| jones_pancreas | hsa04720:Long-term potentiation | 0.00179 | 0.000259 | 61 | 170 | 7 | 163 | 61 | 8879 |
| jones_pancreas | hsa04120:Ubiquitin mediated proteolysis | 0.00179 | 0.000269 | 105 | 170 | 9 | 161 | 105 | 8835 |
| jones_pancreas | hsa05210:Colorectal cancer | 0.00181 | 0.000284 | 83 | 170 | 8 | 162 | 83 | 8857 |
| jones_pancreas | hsa05211:Renal cell carcinoma | 0.00245 | 0.000403 | 66 | 170 | 7 | 163 | 66 | 8874 |
| jones_pancreas | hsa04020:Calcium signaling pathway | 0.00405 | 0.000695 | 147 | 170 | 10 | 160 | 147 | 8793 |
| jones_pancreas | hsa00561:Glycerolipid metabolism | 0.0044 | 0.000785 | 19 | 170 | 4 | 166 | 19 | 8921 |
| jones_pancreas | hsa04810:Regulation of actin cytoskeleton | 0.00494 | 0.000917 | 181 | 170 | 11 | 159 | 181 | 8759 |
| jones_pancreas | hsa04916:Melanogenesis | 0.00525 | 0.00101 | 78 | 170 | 7 | 163 | 78 | 8862 |
| jones_pancreas | hsa04210:Apoptosis | 0.00542 | 0.00108 | 79 | 170 | 7 | 163 | 79 | 8861 |
| jones_pancreas | hsa01510:Neurodegenerative Diseases | 0.00559 | 0.00116 | 38 | 170 | 5 | 165 | 38 | 8902 |
| jones_pancreas | hsa04110:Cell cycle | 0.00562 | 0.00121 | 105 | 170 | 8 | 162 | 105 | 8835 |
| jones_pancreas | hsa04115:p53 signaling pathway | 0.00562 | 0.00128 | 59 | 170 | 6 | 164 | 59 | 8881 |
| jones_pancreas | hsa05214:Glioma | 0.00562 | 0.00128 | 59 | 170 | 6 | 164 | 59 | 8881 |
| jones_pancreas | hsa05218:Melanoma | 0.00744 | 0.00175 | 63 | 170 | 6 | 164 | 63 | 8877 |
| jones_pancreas | hsa05060:Prion disease | 0.00994 | 0.00246 | 12 | 170 | 3 | 167 | 12 | 8928 |
| jones_pancreas | hsa05040:Huntington's disease | 0.00994 | 0.00249 | 27 | 170 | 4 | 166 | 27 | 8913 |
| jones_pancreas | hsa05010:Alzheimer's disease | 0.0109 | 0.0028 | 28 | 170 | 4 | 166 | 28 | 8912 |
| jones_pancreas | hsa04650:Natural killer cell mediated cytotoxicity | 0.0194 | 0.00513 | 106 | 170 | 7 | 163 | 106 | 8834 |
| jones_pancreas | hsa04360:Axon guidance | 0.0218 | 0.00591 | 109 | 170 | 7 | 163 | 109 | 8831 |
| jones_pancreas | hsa05215:Prostate cancer | 0.0225 | 0.00627 | 83 | 170 | 6 | 164 | 83 | 8857 |
| jones_pancreas | hsa01031:Glycan structures - biosynthesis 2 | 0.0232 | 0.00663 | 18 | 170 | 3 | 167 | 18 | 8922 |
| jones_pancreas | hsa00562:Inositol phosphate metabolism | 0.0232 | 0.00692 | 37 | 170 | 4 | 166 | 37 | 8903 |
| jones_pancreas | hsa04012:ErbB signaling pathway | 0.0232 | 0.00697 | 85 | 170 | 6 | 164 | 85 | 8855 |
| jones_pancreas | hsa04662:B cell receptor signaling pathway | 0.0233 | 0.00715 | 60 | 170 | 5 | 165 | 60 | 8880 |
| jones_pancreas | hsa04060:Cytokine-cytokine receptor interaction | 0.0235 | 0.00739 | 207 | 170 | 10 | 160 | 207 | 8733 |
| jones_pancreas | hsa04660:T cell receptor signaling pathway | 0.0241 | 0.00773 | 87 | 170 | 6 | 164 | 87 | 8853 |
| jones_pancreas | hsa04370:VEGF signaling pathway | 0.0242 | 0.00811 | 62 | 170 | 5 | 165 | 62 | 8878 |
| jones_pancreas | hsa04620:Toll-like receptor signaling pathway | 0.0242 | 0.00814 | 88 | 170 | 6 | 164 | 88 | 8852 |
| jones_pancreas | hsa05130:Pathogenic Escherichia coli infection - EHEC | 0.0254 | 0.00889 | 40 | 170 | 4 | 166 | 40 | 8900 |
| jones_pancreas | hsa05131:Pathogenic Escherichia coli infection - EPEC | 0.0254 | 0.00889 | 40 | 170 | 4 | 166 | 40 | 8900 |
| jones_pancreas | hsa04610:Complement and coagulation cascades | 0.0269 | 0.0103 | 66 | 170 | 5 | 165 | 66 | 8874 |
| jones_pancreas | hsa04664:Fc epsilon RI signaling pathway | 0.0269 | 0.0103 | 66 | 170 | 5 | 165 | 66 | 8874 |
| jones_pancreas | hsa04930:Type II diabetes mellitus | 0.0269 | 0.0104 | 42 | 170 | 4 | 166 | 42 | 8898 |
| jones_pancreas | hsa05217:Basal cell carcinoma | 0.0269 | 0.0104 | 42 | 170 | 4 | 166 | 42 | 8898 |
| jones_pancreas | hsa05219:Bladder cancer | 0.0269 | 0.0104 | 42 | 170 | 4 | 166 | 42 | 8898 |
| jones_pancreas | hsa04670:Leukocyte transendothelial migration | 0.0317 | 0.0125 | 97 | 170 | 6 | 164 | 97 | 8843 |
| jones_pancreas | hsa05216:Thyroid cancer | 0.0489 | 0.0196 | 28 | 170 | 3 | 167 | 28 | 8912 |
| jones_pancreas | hsa04912:GnRH signaling pathway | 0.0543 | 0.0221 | 81 | 170 | 5 | 165 | 81 | 8859 |
| jones_pancreas | hsa05221:Acute myeloid leukemia | 0.0647 | 0.0268 | 57 | 170 | 4 | 166 | 57 | 8883 |
| jones_pancreas | hsa00564:Glycerophospholipid metabolism | 0.069 | 0.0291 | 33 | 170 | 3 | 167 | 33 | 8907 |
| jones_pancreas | hsa04910:Insulin signaling pathway | 0.07 | 0.0304 | 120 | 170 | 6 | 164 | 120 | 8820 |
| jones_pancreas | hsa00512:O-Glycan biosynthesis | 0.07 | 0.031 | 13 | 170 | 2 | 168 | 13 | 8927 |
| jones_pancreas | hsa00530:Aminosugars metabolism | 0.07 | 0.031 | 13 | 170 | 2 | 168 | 13 | 8927 |
| jones_pancreas | hsa01030:Glycan structures - biosynthesis 1 | 0.0847 | 0.0381 | 37 | 170 | 3 | 167 | 37 | 8903 |
| jones_pancreas | hsa00640:Propanoate metabolism | 0.0857 | 0.0392 | 15 | 170 | 2 | 168 | 15 | 8925 |
| jones_pancreas | hsa05020:Parkinson's disease | 0.114 | 0.0528 | 18 | 170 | 2 | 168 | 18 | 8922 |
| jones_pancreas | hsa04340:Hedgehog signaling pathway | 0.115 | 0.054 | 43 | 170 | 3 | 167 | 43 | 8897 |
| jones_pancreas | hsa05030:Amyotrophic lateral sclerosis (ALS) | 0.120 | 0.0577 | 19 | 170 | 2 | 168 | 19 | 8921 |
| jones_pancreas | hsa04150:mTOR signaling pathway | 0.136 | 0.0662 | 47 | 170 | 3 | 167 | 47 | 8893 |
| jones_pancreas | hsa04320:Dorso-ventral axis formation | 0.146 | 0.0731 | 22 | 170 | 2 | 168 | 22 | 8918 |
| jones_pancreas | hsa04742:Taste transduction | 0.146 | 0.0731 | 22 | 170 | 2 | 168 | 22 | 8918 |
| jones_pancreas | hsa00240:Pyrimidine metabolism | 0.157 | 0.0794 | 51 | 170 | 3 | 167 | 51 | 8889 |
| jones_pancreas | hsa00230:Purine metabolism | 0.170 | 0.0873 | 86 | 170 | 4 | 166 | 86 | 8854 |
| jones_pancreas | hsa00310:Lysine degradation | 0.170 | 0.0897 | 25 | 170 | 2 | 168 | 25 | 8915 |
| jones_pancreas | hsa03022:Basal transcription factors | 0.170 | 0.0897 | 25 | 170 | 2 | 168 | 25 | 8915 |
| jones_pancreas | hsa04940:Type I diabetes mellitus | 0.212 | 0.113 | 29 | 170 | 2 | 168 | 29 | 8911 |
| jones_pancreas | hsa04920:Adipocytokine signaling pathway | 0.216 | 0.117 | 61 | 170 | 3 | 167 | 61 | 8879 |
| jones_pancreas | hsa00380:Tryptophan metabolism | 0.217 | 0.119 | 30 | 170 | 2 | 168 | 30 | 8910 |
| jones_pancreas | hsa00632:Benzoate degradation via CoA ligation | 0.308 | 0.172 | 9 | 170 | 1 | 169 | 9 | 8931 |
| jones_pancreas | hsa04640:Hematopoietic cell lineage | 0.308 | 0.174 | 74 | 170 | 3 | 167 | 74 | 8866 |
| jones_pancreas | hsa04330:Notch signaling pathway | 0.323 | 0.184 | 40 | 170 | 2 | 168 | 40 | 8900 |
| jones_pancreas | hsa00120:Bile acid biosynthesis | 0.324 | 0.187 | 10 | 170 | 1 | 169 | 10 | 8930 |
| jones_pancreas | hsa00360:Phenylalanine metabolism | 0.333 | 0.202 | 11 | 170 | 1 | 169 | 11 | 8929 |
| jones_pancreas | hsa00361:gamma-Hexachlorocyclohexane degradation | 0.333 | 0.202 | 11 | 170 | 1 | 169 | 11 | 8929 |
| jones_pancreas | hsa00591:Linoleic acid metabolism | 0.333 | 0.202 | 11 | 170 | 1 | 169 | 11 | 8929 |
| jones_pancreas | hsa00903:Limonene and pinene degradation | 0.333 | 0.202 | 11 | 170 | 1 | 169 | 11 | 8929 |
| jones_pancreas | hsa04710:Circadian rhythm | 0.354 | 0.217 | 12 | 170 | 1 | 169 | 12 | 8928 |
| jones_pancreas | hsa03020:RNA polymerase | 0.396 | 0.246 | 14 | 170 | 1 | 169 | 14 | 8926 |
| jones_pancreas | hsa00980:Metabolism of xenobiotics by cytochrome P450 | 0.414 | 0.260 | 15 | 170 | 1 | 169 | 15 | 8925 |
| jones_pancreas | hsa00970:Aminoacyl-tRNA biosynthesis | 0.427 | 0.274 | 16 | 170 | 1 | 169 | 16 | 8924 |
| jones_pancreas | hsa04614:Renin-angiotensin system | 0.427 | 0.274 | 16 | 170 | 1 | 169 | 16 | 8924 |
| jones_pancreas | hsa00252:Alanine and aspartate metabolism | 0.473 | 0.314 | 19 | 170 | 1 | 169 | 19 | 8921 |
| jones_pancreas | hsa02010:ABC transporters - General | 0.473 | 0.314 | 19 | 170 | 1 | 169 | 19 | 8921 |
| jones_pancreas | hsa04740:Olfactory transduction | 0.473 | 0.314 | 19 | 170 | 1 | 169 | 19 | 8921 |
| jones_pancreas | hsa00020:Citrate cycle (TCA cycle) | 0.477 | 0.327 | 20 | 170 | 1 | 169 | 20 | 8920 |
| jones_pancreas | hsa00251:Glutamate metabolism | 0.477 | 0.327 | 20 | 170 | 1 | 169 | 20 | 8920 |
| jones_pancreas | hsa00260:Glycine, serine and threonine metabolism | 0.477 | 0.327 | 20 | 170 | 1 | 169 | 20 | 8920 |
| jones_pancreas | hsa00620:Pyruvate metabolism | 0.49 | 0.340 | 21 | 170 | 1 | 169 | 21 | 8919 |
| jones_pancreas | hsa00330:Arginine and proline metabolism | 0.515 | 0.364 | 23 | 170 | 1 | 169 | 23 | 8917 |
| jones_pancreas | hsa00350:Tyrosine metabolism | 0.515 | 0.364 | 23 | 170 | 1 | 169 | 23 | 8917 |
| jones_pancreas | hsa00790:Folate biosynthesis | 0.526 | 0.376 | 24 | 170 | 1 | 169 | 24 | 8916 |
| jones_pancreas | hsa00590:Arachidonic acid metabolism | 0.553 | 0.399 | 26 | 170 | 1 | 169 | 26 | 8914 |
| jones_pancreas | hsa03320:PPAR signaling pathway | 0.677 | 0.493 | 35 | 170 | 1 | 169 | 35 | 8905 |
| jones_pancreas | hsa00500:Starch and sucrose metabolism | 0.683 | 0.503 | 36 | 170 | 1 | 169 | 36 | 8904 |
| jones_pancreas | hsa00010:Glycolysis / Gluconeogenesis | 1 | 1 | 38 | 170 | 0 | 170 | 38 | 8902 |
| jones_pancreas | hsa00030:Pentose phosphate pathway | 1 | 1 | 18 | 170 | 0 | 170 | 18 | 8922 |
| jones_pancreas | hsa00051:Fructose and mannose metabolism | 1 | 1 | 22 | 170 | 0 | 170 | 22 | 8918 |
| jones_pancreas | hsa00052:Galactose metabolism | 1 | 1 | 17 | 170 | 0 | 170 | 17 | 8923 |
| jones_pancreas | hsa00071:Fatty acid metabolism | 1 | 1 | 18 | 170 | 0 | 170 | 18 | 8922 |
| jones_pancreas | hsa00100:Biosynthesis of steroids | 1 | 1 | 11 | 170 | 0 | 170 | 11 | 8929 |
| jones_pancreas | hsa00150:Androgen and estrogen metabolism | 1 | 1 | 14 | 170 | 0 | 170 | 14 | 8926 |
| jones_pancreas | hsa00190:Oxidative phosphorylation | 1 | 1 | 49 | 170 | 0 | 170 | 49 | 8891 |
| jones_pancreas | hsa00220:Urea cycle and metabolism of amino groups | 1 | 1 | 14 | 170 | 0 | 170 | 14 | 8926 |
| jones_pancreas | hsa00280:Valine, leucine and isoleucine degradation | 1 | 1 | 14 | 170 | 0 | 170 | 14 | 8926 |
| jones_pancreas | hsa00340:Histidine metabolism | 1 | 1 | 16 | 170 | 0 | 170 | 16 | 8924 |
| jones_pancreas | hsa00410:beta-Alanine metabolism | 1 | 1 | 11 | 170 | 0 | 170 | 11 | 8929 |
| jones_pancreas | hsa00440:Aminophosphonate metabolism | 1 | 1 | 10 | 170 | 0 | 170 | 10 | 8930 |
| jones_pancreas | hsa00450:Selenoamino acid metabolism | 1 | 1 | 13 | 170 | 0 | 170 | 13 | 8927 |
| jones_pancreas | hsa00480:Glutathione metabolism | 1 | 1 | 16 | 170 | 0 | 170 | 16 | 8924 |
| jones_pancreas | hsa00510:N-Glycan biosynthesis | 1 | 1 | 17 | 170 | 0 | 170 | 17 | 8923 |
| jones_pancreas | hsa00511:N-Glycan degradation | 1 | 1 | 8 | 170 | 0 | 170 | 8 | 8932 |
| jones_pancreas | hsa00565:Ether lipid metabolism | 1 | 1 | 16 | 170 | 0 | 170 | 16 | 8924 |
| jones_pancreas | hsa00600:Sphingolipid metabolism | 1 | 1 | 18 | 170 | 0 | 170 | 18 | 8922 |
| jones_pancreas | hsa00626:Naphthalene and anthracene degradation | 1 | 1 | 10 | 170 | 0 | 170 | 10 | 8930 |
| jones_pancreas | hsa00650:Butanoate metabolism | 1 | 1 | 18 | 170 | 0 | 170 | 18 | 8922 |
| jones_pancreas | hsa00710:Carbon fixation | 1 | 1 | 15 | 170 | 0 | 170 | 15 | 8925 |
| jones_pancreas | hsa00740:Riboflavin metabolism | 1 | 1 | 11 | 170 | 0 | 170 | 11 | 8929 |
| jones_pancreas | hsa00860:Porphyrin and chlorophyll metabolism | 1 | 1 | 13 | 170 | 0 | 170 | 13 | 8927 |
| jones_pancreas | hsa00910:Nitrogen metabolism | 1 | 1 | 13 | 170 | 0 | 170 | 13 | 8927 |
| jones_pancreas | hsa00930:Caprolactam degradation | 1 | 1 | 10 | 170 | 0 | 170 | 10 | 8930 |
| jones_pancreas | hsa01032:Glycan structures - degradation | 1 | 1 | 14 | 170 | 0 | 170 | 14 | 8926 |
| jones_pancreas | hsa03010:Ribosome | 1 | 1 | 41 | 170 | 0 | 170 | 41 | 8899 |
| jones_pancreas | hsa03030:DNA polymerase | 1 | 1 | 21 | 170 | 0 | 170 | 21 | 8919 |
| jones_pancreas | hsa03050:Proteasome | 1 | 1 | 21 | 170 | 0 | 170 | 21 | 8919 |
| jones_pancreas | hsa04130:SNARE interactions in vesicular transport | 1 | 1 | 27 | 170 | 0 | 170 | 27 | 8913 |
| jones_pancreas | hsa04140:Regulation of autophagy | 1 | 1 | 16 | 170 | 0 | 170 | 16 | 8924 |
| jones_pancreas | hsa04612:Antigen processing and presentation | 1 | 1 | 54 | 170 | 0 | 170 | 54 | 8886 |
| jones_pancreas | hsa04950:Maturity onset diabetes of the young | 1 | 1 | 18 | 170 | 0 | 170 | 18 | 8922 |
| jones_pancreas | hsa05050:Dentatorubropallidoluysian atrophy (DRPLA) | 1 | 1 | 13 | 170 | 0 | 170 | 13 | 8927 |
| jones_pancreas | hsa05110:Cholera - Infection | 1 | 1 | 28 | 170 | 0 | 170 | 28 | 8912 |
| jones_pancreas | hsa05120:Epithelial cell signaling in Helicobacter pylori infection | 1 | 1 | 53 | 170 | 0 | 170 | 53 | 8887 |